Published in:
28-10-2021 | Parotid Gland Tumor | Correction
Correction to: Outcomes of retesting in patients with previously uninformative cancer genetics evaluations
Published in: Familial Cancer | Issue 3/2022
Login to get accessExcerpt
In Table 4 of the article “Outcomes of retesting in patients with previously uninformative cancer genetics evaluations” Authored by “Shenin A. Dettwyler, Erika S. Koeppe, Michelle F. Jacobs, Elena M. Stoffel, the data in the “Retest PV,” “Retest VUS, “and “Retest Negative “ columns do not align properly with the types of cancer in the first column. The correct Table 4 has been provided below.
Table 4
Cancer diagnoses and non-malignant manifestations in affected patients (n = 104)
|
Retest PV, n = 21 (20.2%)
|
Retest VUS, n = 10 (9.6%)
|
Retest negative, n = 73 (70.2%)
|
pa
|
|
|---|---|---|---|---|
|
Mean age at first diagnosis; years, (range)
Total: 42.5 (2–73)
|
38.9 (11–73)
|
35.8 (5–53)
|
44.5 (2–69)
|
0.26
|
|
≥ 2 primary diagnoses
Total: n = 42 (40.4%)
|
8 (19%)
|
6 (14.3%)
|
28 (66.7%)
|
0.10
|
|
Cancer type/non-malignant manifestationb,c
|
||||
|
Female breast (n = 42, 40.4%)
|
8 (19%)
|
3 (7.1%)
|
31 (73.8%)
|
|
|
Melanoma (n = 27, 26%)
|
3 (11.1%)
|
2 (7.4%)
|
22 (81.5%)
|
|
|
Colorectal (n = 21, 20.2%)
|
2 (9.5%)
|
3 (14.3%)
|
16 (76.2%)
|
|
|
Otherd (n = 12, 11.5%)
|
4 (33.3%)
|
2 (16.7%)
|
5 (41.7%)
|
|
|
Sarcoma (n = 10, 9.6%)
|
3 (30%)
|
0
|
7 (70%)
|
|
|
PGL/PCC (n = 9, 8.7%)
|
2 (22.2%)
|
1 (11.1%)
|
6 (66.7%)
|
|
|
Thyroid (n = 8, 7.7%)
|
1 (12.5%)
|
1 (12.5%)
|
6 (75%)
|
|
|
Endometrial (n = 6, 5.8%)
|
2 (33.3%)
|
0
|
4 (66.7%)
|
> 0.05
|
|
Ovarian (n = 5, 4.8%)
|
2 (40%)
|
2 (40%)
|
1 (20%)
|
|
|
Polyposise (n = 5, 4.8%)
|
3 (60%)
|
0
|
2 (40%)
|
|
|
Genitourinary (n = 3, 2.9%)
|
0
|
0
|
3 (100%)
|
|
|
Leukemia (n = 3, 2.9%)
|
0
|
0
|
3 (100%)
|
|
|
ACC (n = 3, 2.9%)
|
0
|
0
|
3 (100%)
|
|
|
Oral SCC (n = 2, 1.9%)
|
2 (100%)
|
0
|
0
|
|
|
Brain (n = 2, 1.9%)
|
1 (50%)
|
1 (50%)
|
0
|
|
|
HL (n = 2, 1.9%)
|
1 (50%)
|
1 (50%)
|
0
|
|
|
Hypercalcemia (n = 2, 1.9%)
|
1 (50%)
|
1 (50%)
|
0
|
|
|
Male breast (n = 2, 1.9%)
|
0
|
0
|
2 (100%)
|
|
|
Prostate (n = 2, 1.9%)
|
0
|
0
|
2 (100%)
|
|
|
Lung (n = 2, 1.9%)
|
0
|
0
|
2 (100%)
|
|